Extracorporeal Membrane Oxygenation in a case of opioid-induced acute respiratory distress syndrome

IF 0.3 Q4 CRITICAL CARE MEDICINE

Egyptian Journal of Critical Care Medicine Pub Date : 2016-04-01 DOI:10.1016/j.ejccm.2016.02.007

Ahmad Abdalmohsen Said, Mohamed Khaled, Alia H. Abdalfattah, Akram Abdelbary Ahmed

{"title":"Extracorporeal Membrane Oxygenation in a case of opioid-induced acute respiratory distress syndrome","authors":"Ahmad Abdalmohsen Said, Mohamed Khaled, Alia H. Abdalfattah, Akram Abdelbary Ahmed","doi":"10.1016/j.ejccm.2016.02.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Currently Extracorporeal Membrane Oxygenation (ECMO) is used for long-term support of respiratory and/or cardiac function, ECMO is primarily indicated for patients with temporary severe ventilation and/or oxygenation problems that they are unlikely to survive conventional lung protective mechanical ventilation.</p></div><div><h3>Aim of the work</h3><p>We describe our experience in the management of a case of opioid-induced acute respiratory distress syndrome with ECMO.</p></div><div><h3>Methods</h3><p>A 22year old female, known Heroin addict, admitted with severe ARDS, failed to improve with conventional ventilation, Murray Lung Injury Score was 3.5, RESP score (8) was 4, underwent Veno-venous (V-V) ECMO via femoro-atrial approach using Maquet Cardiohelp console. The ECMO run duration was 12days. Successful decannulation was done after weaning off ECMO by decreasing FiO<sub>2</sub> on ECMO, and continuing mechanical ventilation on pressure support ventilation.</p></div><div><h3>Results</h3><p>Successful weaning of ECMO on day 12 and successful extubation on day 14.</p></div><div><h3>Conclusion</h3><p>ECMO can be used safely and successfully in the treatment of Heroin induced ARDS.</p></div>","PeriodicalId":31233,"journal":{"name":"Egyptian Journal of Critical Care Medicine","volume":"4 1","pages":"Pages 39-42"},"PeriodicalIF":0.3000,"publicationDate":"2016-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejccm.2016.02.007","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Critical Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S209073031600013X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}

引用次数: 3

Abstract

Introduction

Currently Extracorporeal Membrane Oxygenation (ECMO) is used for long-term support of respiratory and/or cardiac function, ECMO is primarily indicated for patients with temporary severe ventilation and/or oxygenation problems that they are unlikely to survive conventional lung protective mechanical ventilation.

Aim of the work

We describe our experience in the management of a case of opioid-induced acute respiratory distress syndrome with ECMO.

Methods

A 22 year old female, known Heroin addict, admitted with severe ARDS, failed to improve with conventional ventilation, Murray Lung Injury Score was 3.5, RESP score (8) was 4, underwent Veno-venous (V-V) ECMO via femoro-atrial approach using Maquet Cardiohelp console. The ECMO run duration was 12 days. Successful decannulation was done after weaning off ECMO by decreasing FiO₂ on ECMO, and continuing mechanical ventilation on pressure support ventilation.

Results

Successful weaning of ECMO on day 12 and successful extubation on day 14.

Conclusion

ECMO can be used safely and successfully in the treatment of Heroin induced ARDS.

查看原文本刊更多论文

阿片类药物引起的急性呼吸窘迫综合征1例体外膜氧合

目前体外膜氧合(ECMO)用于呼吸和/或心脏功能的长期支持，ECMO主要适用于有暂时严重通气和/或氧合问题的患者，这些患者不太可能在传统的肺保护性机械通气中存活下来。我们描述了我们的经验，在管理阿片类药物引起的急性呼吸窘迫综合征与ECMO的情况下。方法22岁女性，已知海洛因依赖者，重度ARDS入院，常规通气未能改善，Murray肺损伤评分为3.5分，RESP评分(8)为4分，采用Maquet心脏辅助台经股房入路行静脉-静脉(V-V) ECMO。ECMO运行时间为12天。停用ECMO后，通过降低体外氧合(FiO2)，在压力支持通气下继续机械通气，成功脱管。结果第12天ECMO成功脱机，第14天成功拔管。结论体外氧合治疗海洛因致ARDS安全、成功。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Egyptian Journal of Critical Care Medicine

自引率

0.00%

发文量

审稿时长

42 weeks

期刊介绍： The Egyptian Journal of Critical Care Medicine is the official Journal of the Egyptian College of Critical Care Physicians, the most authoritative organization of Egyptian physicians involved in the multi-professional field of critical care medicine. The journal is intended to provide a peer-reviewed source for multidisciplinary coverage of general acute and intensive care medicine and its various subcategories including cardiac, pulmonary, neuro, renal as well as post-operative care. The journal is proud to have an international multi-professional editorial board in the broad field of critical care that will assist in publishing promising research and breakthrough reports that lead to better patients care in life threatening conditions, and bring the reader a quick access to the latest diagnostic and therapeutic approaches in monitoring and management of critically ill patients.